https://ir.icecure-medical.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_54f40390b69697dace3343a57e47c1a7/icecuremedical/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.icecure-medical.com/news-events/press-releases/detail/217/icecure-participates-in-society-of-breast-imaging-symposium-2026-as-u-s-prosense-revenue-increases-by-30-in-first-quarter-of-2026-compared-to-first-quarter-of-2025 Tue, 21 Apr 26 08:30:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/217/icecure-participates-in-society-of-breast-imaging-symposium-2026-as-u-s-prosense-revenue-increases-by-30-in-first-quarter-of-2026-compared-to-first-quarter-of-2025 https://ir.icecure-medical.com/news-events/press-releases/detail/216/icecure-announces-pricing-of-4-0-million-registered-direct-offering-and-concurrent-private-placement Thu, 26 Mar 26 08:00:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/216/icecure-announces-pricing-of-4-0-million-registered-direct-offering-and-concurrent-private-placement https://ir.icecure-medical.com/news-events/press-releases/detail/215/icecure-reports-positive-5-year-top-line-results-from-icesecret-kidney-cancer-cryoablation-study-89-4-and-83-9-recurrence-free-rates Wed, 25 Mar 26 08:30:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/215/icecure-reports-positive-5-year-top-line-results-from-icesecret-kidney-cancer-cryoablation-study-89-4-and-83-9-recurrence-free-rates https://ir.icecure-medical.com/news-events/press-releases/detail/214/icecure-appoints-meir-peleg-as-chief-financial-officer Tue, 24 Mar 26 08:30:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/214/icecure-appoints-meir-peleg-as-chief-financial-officer https://ir.icecure-medical.com/news-events/press-releases/detail/213/icecure-reports-2025-full-year-financial-operational-results Tue, 17 Mar 26 08:30:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/213/icecure-reports-2025-full-year-financial-operational-results https://ir.icecure-medical.com/news-events/press-releases/detail/212/u-s-fda-approves-icecures-post-marketing-choice-study-for-prosense-cryoablation-in-the-local-treatment-of-low-risk-breast-cancer Wed, 11 Mar 26 08:30:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/212/u-s-fda-approves-icecures-post-marketing-choice-study-for-prosense-cryoablation-in-the-local-treatment-of-low-risk-breast-cancer https://ir.icecure-medical.com/news-events/press-releases/detail/211/icecure-medical-to-report-2025-full-year-financial-and-operating-results-on-march-17-2026 Tue, 10 Mar 26 08:30:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/211/icecure-medical-to-report-2025-full-year-financial-and-operating-results-on-march-17-2026 https://ir.icecure-medical.com/news-events/press-releases/detail/210/american-society-of-breast-surgeons-asbrs-resource-guide-update-recommends-cryoablation-for-low-risk-breast-cancer Mon, 09 Mar 26 08:30:00 -0400 https://ir.icecure-medical.com/news-events/press-releases/detail/210/american-society-of-breast-surgeons-asbrs-resource-guide-update-recommends-cryoablation-for-low-risk-breast-cancer https://ir.icecure-medical.com/news-events/press-releases/detail/209/icecure-medical-reports-independent-study-published-in-plos-one-demonstrating-prosense-cryoablation-safe-and-effective-in-treatment-of-breast-fibroadenomas Mon, 02 Mar 26 08:30:00 -0500 https://ir.icecure-medical.com/news-events/press-releases/detail/209/icecure-medical-reports-independent-study-published-in-plos-one-demonstrating-prosense-cryoablation-safe-and-effective-in-treatment-of-breast-fibroadenomas https://ir.icecure-medical.com/news-events/press-releases/detail/208/icecure-medical-successfully-completes-5-year-patient-follow-up-in-icesecret-kidney-cancer-cryoablation-study-final-analysis-expected-in-second-quarter-of-2026 Mon, 23 Feb 26 08:30:00 -0500 https://ir.icecure-medical.com/news-events/press-releases/detail/208/icecure-medical-successfully-completes-5-year-patient-follow-up-in-icesecret-kidney-cancer-cryoablation-study-final-analysis-expected-in-second-quarter-of-2026